Biotechnology Fund is trading at 42.07 as of the 22nd of March 2025; that is 0.33 percent increase since the beginning of the trading day. The fund's open price was 41.93. Biotechnology Fund has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. More on Biotechnology Fund Class
Biotechnology Fund Class [RYCFX] is traded in USA and was established 22nd of March 2025. The fund is listed under Health category and is part of Rydex Funds family. This fund at this time has accumulated 117.21 M in assets with no minimum investment requirementsBiotechnology Fund Class is currently producing year-to-date (YTD) return of 3.52%, while the total return for the last 3 years was 3.59%.
Check Biotechnology Fund Probability Of Bankruptcy
Instrument Allocation
Top Biotechnology Fund Class Mutual Fund Constituents
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.